Diabetes - Perspectives in Drug Therapy by Mathias SchwanstecherDiabetes - Perspectives in Drug Therapy by Mathias Schwanstecher

Diabetes - Perspectives in Drug Therapy

byMathias Schwanstecher

Paperback | April 21, 2013

Pricing and Purchase Info

$564.72 online 
$689.95 list price save 18%
Earn 2,824 plum® points

Prices and offers may vary in store


In stock online

Ships free on orders over $25

Not available in stores


The chapters of this book report cutting-edge research on molecular events in adiposity and type 2 diabetes, thus opening the way for innovative drug-based therapeutic strategies. It addresses all those who wish to keep in touch with recent developments in the field.
Title:Diabetes - Perspectives in Drug TherapyFormat:PaperbackDimensions:408 pages, 23.5 × 15.5 × 0.07 inPublished:April 21, 2013Publisher:Springer-Verlag/Sci-Tech/TradeLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:3642267424

ISBN - 13:9783642267420

Look for similar items by category:


Table of Contents

Preface. Targeting type 2 diabetes. Dual acting and pan-PPAR activators as potential anti-diabetic therapies. GLP-agonists and Dipeptidyl-Peptidase IV Inhibitors. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. SGLT Inhibitors as New Therapeutic Tools in the Treatment of Diabetes. Inhibitors of 11b-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy. Nampt and its potential role in inflammation and type 2 diabetes. Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance. Overcoming Insulin Resistance with Ciliary Neurotrophic Factor. Thermogenesis and related metabolic targets in anti-diabetic therapy. Interleukin targeted therapy for metabolic syndrome and type 2 diabetes. Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes. AMP-activated protein kinase and metabolic control. Mitochondria as potential targets in antidiabetic therapy. Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects